610
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Association of cortisol with neuropsychological assessment in older adults with generalized anxiety disorder

, , &
Pages 432-440 | Received 28 Aug 2012, Accepted 15 Dec 2012, Published online: 22 Jan 2013
 

Abstract

Objectives: Older adults with generalized anxiety disorder (GAD) have elevated diurnal cortisol patterns and show an increased cortisol stress response, which may increase risk for cognitive dysfunction. The current secondary data analysis examined how neuropsychological assessment as a possible laboratory stressor affects cortisol levels in late-life GAD and, in turn, how cortisol levels affect cognitive performance.

Methods: The current sample consisted of 69 individuals with late-life GAD and 39 psychiatrically healthy group-matched comparison participants. Cognitive performance was measured with a neuropsychological battery and salivary cortisol was collected at several time points. Hierarchical regressions were performed to assess the moderating role of cortisol in the relationship between GAD status and cognitive performance.

Results: The results revealed that older adults with GAD showed significantly lower cortisol levels during neuropsychological assessment, compared to their baseline levels. Further, there was a significant interaction between post-neuropsychological assessment cortisol levels and GAD status on several measures of cognitive performance. The interaction indicated that there is a significant negative relationship between cortisol level and cognitive performance in the GAD participants and no such relationship in the comparison participants.

Conclusions: Our results revealed that participating in a neuropsychological assessment was associated with reduced cortisol in GAD participants, suggesting that refocusing attention such as engaging in cognitive tasks had a cortisol-lowering effect. Further, a higher cortisol level appears to have a detrimental effect on cognitive performance for individuals with GAD, but not psychiatrically healthy comparison participants. The methodological and treatment implications of these findings are discussed.

Acknowledgments

Dr Kerri Rawson is now a Postdoctoral Researcher in the Department of Psychiatry at Washington University School of Medicine.

Funding

This study was supported by National Institute of Mental Health (R01 MH070547 to E.J.L; R01 MH072947 to Meryl A. Butters) and the Washington University Institute of Clinical and Translational Sciences Clinical Research Training Center Postdoctoral Program (UL1 RR024992 to Chirstopher B. Rosnick). The National Institute of Mental Health and Clinical Research Training Center had no role in the study design, analysis, interpretation, writing of the manuscript, or the decision to submit the manuscript for publication.

Conflicts of interests

Dr Lenze reports the following potential conflicts of interest (current and past three years): research funding from Forest Laboratories, Roche, Johnson & Johnson, and Lundbeck; and consulting payments from Fox Learning Systems. The other authors report no potential conflicts.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.